<p>Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to&nbsp;hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in&nbsp;saturated fat&nbsp;and cholesterol and other non-pharmacologic measures alone has been inadequate.</p>